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The methanol extract of Hypnea musciformis inhibited the growth of 66% of the Gram +ve
bacteria tested. The crude extracts inhibited the growth of Staphylococcus aureus,
Pseudomonas aeruginosa and Vibrio alginolyticus by producing highest inhibitory zone
range of 113.04 mm2.
 In the aqueous extract, the activity was comparatively less specifically
towards Gram -ve bacteria. It was also noted that the Hexane-Benzene (80:20%) fraction
(HB5a) of H. musciformis exhibited potent activity not only against Gram -ve bacteria but
also against Gram +ve Staphylococcus aureus. The higher bacterial inhibition zones (>78.5
mm2) were recorded in the methanol extracts of macroalgae for Staphylococcus aureus,
Vibrio alginolyticus and Pseudomonas aeruginosa and also compared to the commercial
antibiotics. The Hypnea valentiae extract at 0.1% was most active against Staphylococcus
aureus, Vibrio fischeri, V. alginolyticus, Pseudomonas aeruginosa and Micrococcus luteus at
20oC.
Introduction
The oceans have extensive
biodiversity of marine organisms and huge
resource potential to provide many complex
chemical compounds with functional materials
including polyunsaturated fatty acids (PUFA),
polysaccharides, essential minerals and
vitamins, antioxidants, enzymes and bioactive
peptides (Murty and Agrawal, 2010). Among
marine organisms, macroalgae are rich sources
of structurally diverse bioactive compounds
with different bioactivity spectra and
biomedical value (Yuvaraj et al., 2011).
Research and utilization of marine algal
community have increased markedly that
directly offers enormous untapped reservoir
of novel drug leads endowed with ingenious
structures and potential biological activities
(Kolanjinathan and Stella, 2011).
The use of antibiotics increased
significantly due to heavy infections and the
pathogenic bacteria becoming resistant to
drugs necessitated the development of new
antibacterial compounds from marine
macroalgae. Many of these could be
developed into antiseptics and cleansing
agents, but their antibiotic activity in vivo is
often only achieved at toxic concentrations.
A promising antibacterial agent is a
halogenated furanone or fimbrolide from
Delisea pulchra and has been examined for
its effectiveness as a possible treatment for
chronic Pseudomonas aeruginosa infection.
A study on the 17 different macroalgae
collected from southern India coast indicated
that about 94% exhibited antibiotic activity
towards shrimp and fish pathogens (Smith and
Kitts, 1994).
Red algae, especially many species
of the genus Hypnea (order Gigartinales,
family Hypneaceae) are proven to be rich
sources of halogenated secondary
metabolites. Many of these metabolites
have been found to possess a variety of




and antimicrobial (Chlorellin derivatives,
halogenated compounds such as haloforms,
halogenated alkanes and alkenes, alcohols,
aldehydes, hydroquinones, sterols, ketones,
allolaurinterol) activities (Garg et al., 1992). In
our previous studies, antifouling,
anticoagulant, glucosidase inhibitory
properties (Pramitha et al., 2008), antimicrobial
activities of aqueous extract of macroalgae,
growth responses of microalgae (Pramitha and
Lipton, 2011) and selective cytotoxic activities
of macroalgae from the Indian coast have
already been reported (Pramitha and Lipton,
2012). Though there are diverse studies on
bioactivity to marine flora against several
pathogens, our work on testing the
antibacterial efficacies of macroalgae Hypnea
musciformis and Hypnea valentiae mainly on
human multidrug resistant pathogen and also
on fish pathogens is relatively a new concept,
as few attempts had been made earlier in this
line. Considering such potentials, the marine
macroalgae Hypnea musciformis and Hypnea
valentiae collected from Southeast and
Southwest coast of India were examined and
the findings are presented in this paper.
Materials and Methods
The red macroalgae, Hypnea
valentiae (Turner) Montagne was collected
from the intertidal rocks of Vizhinjam coast
(Lat. 08° 22’N; Long. 76° 59’E) southwest India
and Hypnea musciformis (Wulfen) Lamouroux
was collected from Rameswaram/Mandapam
coast (79° 20’E Long; 09° 25’ N Lat), southeast
India. The collected algal samples were cleaned
and washed with tap water to remove the
associated debris and shade dried at room
temperature (28±2oC) for 5-8 days or until they
are brittle easily by hand. After completely
drying, plant materials were powdered and
extracted with methanol. In this process, 500
g of finely powdered algal material was refluxed
with methanol in a 5 l capacity round bottom
flask. The extract was filtered and concentrated
to recover the excess solvents in another
distillation system. Finally, it was reduced to a
thick viscous crude extract in a rotary vacuum
evaporator (Buchi) at 40°C and the yield of
extract was recorded as 0.085 g dry-1 weight.
Aqueous extracts was prepared by
homogenizing the fresh collection with
required quantity of phosphate buffered saline
(pH 7.4) and the extract was strained using a
strainer. Crude extract (200 mg) was further
fractionated using normal phase column
chromatography, C-40 silica columns (length-
600 mm, bore-30 mm) of mesh size (60-120 µ)
with sintered disc and screw cock. The eluted
fractions were once again evaporated and
concentrated using rotary vacuum evaporator.
The American Type Culture
Collections of Staphylococcus aureus
(ATCC– 25923 through Sree Chithra Thirunal
Institute of Science & Technology,
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Trivandrum), Micrococcus luteus (MTCC-
106), Pseudomonas aeruginosa (MTCC-741),
Aeromonas hydrophila (MTCC-646), Bacillus
subtilis (MTCC-736) and Marine Ornamental
Fish isolates (MOF) from Marine
Biotechnology laboratory, CMFRI, Vizhinjam
such as Serratia marcescens, Vibrio fischeri,
Vibrio alginolyticus, MOF 1 (shrimp isolate)
and  MOF 2 (Clown fish isolate) were initially
activated in nutrient broth and subsequently
purified by agar streak plate method were
used as test bacterial strains.
Disc diffusion method (Bauer et al.,
1996) was carried out on Muller Hinton agar
plates (Hi-media) to determine the in vitro
antibacterial susceptibility of the extracts
against bacterial isolates. About 1/3rd portion
of petri dishes (100 mm) were poured with
Muller-Hinton agar up to 2 mm thickness as a
single layer and allowed to solidify for 15
minutes. After solidification, 0.1 ml of 18 h
bacterial shake culture were surface
inoculated using sterile cotton swabs and
allowed to set for 5 minutes. Sterile discs (6
mm diameter, Hi-media) which were
impregnated with suitable aliquots of desired
concentration of test compound at 30 µl and
were placed on the inoculated agar surface
using sterilized forceps. All the assays were
carried out in triplicate sets with suitable
controls. After incubation at 20°C or 30°C in a
BOD incubator (ROTEK) for 24 h, the area of
inhibition zone (mm2) was determined using a
Hi Antibiotic Zone Scale-C (PW-297, Hi-
media). The area of the inhibition zone was
calculated as Cross diameter of the inhibition
zone = m; Net diameter of the well = n; Net
diameter of the inhibition zone, x = m-n; Net
radius of the inhibition zone, r = x/2; Area of
the inhibition zone = πr2 (π = 3.14).
Results
 The methanol extract of Hypnea
musciformis showed highest activity range of
113.04 mm2 at 20°C against Staphylococcus
aureus, Vibrio alginolyticus and
Pseudomonas aeruginosa. The aqueous
extract of H. musciformis produced same
highest activity towards Staphylococcus
aureus, Psaudomonas aeruginosa and
Micrococcus luteus (113.04 mm2). It was
noteworthy that S. aureus was totally
susceptible at both the incubated
temperatures. The methanol extract of H.
musciformis also found to be active against
Serratia marcescens, Vibrio alginolyticus and
Aeromonas hydrophila (63.58 mm2) at 30°C
and Serratia marcescens (63.58 mm2), Vibrio
fischeri (78.5 mm2), Aeromonas hydrophila
(94.98 mm2), MOF 1 (63.58 mm2) and MOF 2
(78.5 mm2) at 20°C. The methanol and aqueous
extract of H. musciformis exhibited highest
range of inhibitory potential (113.04 mm2)
towards Gram +ve strain of Staphylococcus
aureus (Table-1).
The methanol extracts of Hypnea
valentiae exhibited highest activity (113.04
mm2) at 20°C against Staphylococcus aureus,
Vibrio alginolyticus, Pseudomonas
aeruginosa and Micrococcus luteus. The
Gram -ve bacterium Serratia marcescens was
totally resistant at both the tested incubation
temperatures. Similarly, MOF 1 isolate was
resistant at 30°C and regained a nearly active
range of 63.58 mm2 at 20°C. The Gram +ve
Bacillus subtilis showed active range of
inhibition of 94.98 mm2 at both temperatures
(30°C and 20°C). Hypnea valentiae aqueous
extract produced highest activity against
Vibrio alginolyticus at 20°C and the same was
found to be reduced at 30°C (63.58 mm2).
However, methanol and aqueous extracts of
H. valentiae produced complete inhibitory
effect upon Vibrio alginolyticus at 20°C. In
the case of H. musciformis, Bacillus subtilis
isolate and in H. valentiae, Aeromonas
hydrophila were found to be resistant at 30°C.
It was also noted that in H. valentiae, MOF 1
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Table-1. Zone of inhibition (mm2) of methanol and aqueous extracts of Hypnea musciformis
Test organisms                        Methanol                        Aqueous
30°C 20°C 30°C 20°C
Clinical pathogens
Staphylococcus aureus (Gram +ve) 113.04 113.04 63.58 113.04
Micrococcus luteus (Gram +ve) 38.46 50.24 94.98 113.04
Pseudomonas aeruginosa (Gram -ve) 50.24 113.04 78.5 113.04
Aeromonas hydrophil (Gram -ve) 63.58 94.98 50.24 63.58
Bacillus subtilis (Gram +ve) 38.46 50.24 R 50.24
Fish pathogens
Serratia marcescen (Gram -ve) 63.58 63.58 63.58 63.58
Vibrio fischeri (Gram -ve) 50.24 78.5 50.24 78.5
Vibrio alginolyticus (Gram -ve) 63.58 113.04 94.98 94.98
MOF 1 (Shrimp isolate) (Gram -ve) 50.24 63.58 50.24 50.24
MOF 2 (Clown fish isolate) (Gram -ve) 50.24 78.5 R R
R - Resistant
Table-2. Zone of inhibition (mm2) of methanol and aqueous extracts of Hypnea valentiae
Test organisms                        Methanol                        Aqueous
30°C 20°C 30°C 20°C
Clinical pathogens
Staphylococcus aureus (Gram +ve) 94.98 113.04 63.58 78.5
Micrococcus luteus (Gram +ve) 113.04 113.04 R 78.5
Pseudomonas aeruginosa (Gram -ve) 78.5 113.04 50.24 94.98
Aeromonas hydrophila (Gram -ve) 3.14 7.06 R R
Bacillus subtilis (Gram +ve) 94.98 94.98 50.24 63.58
Fish pathogens
Serratia marcescens (Gram -ve) R R 3.14 R
Vibrio fischeri (Gram -ve) 50.24 78.5 50.24 78.5
Vibrio  alginolyticus (Gram -ve) 63.58 113.04 63.58 113.04
MOF 1 (Shrimp isolate) (Gram -ve) R 63.58 R 63.58
MOF 2 (Clown fish isolate) (Gram -ve) 50.24 50.24 3.14 R
R - Resistant
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isolate was resistant at 30°C and produced an
active range of inhibition (63.58 mm2) at 20°C
(Table-2). The results also indicated that the
aqueous extracts of macroalgae successfully
inhibited Vibrio alginolyticus isolate
followed by Pseudomonas aeruginosa and
Micrococcus luteus at 30°C and 20°C.
Most of the Gram -ve strains, did not
exhibit a higher range of inhibition except
Vibrio alginolyticus and Pseudomonas
aeruginosa. In the case of H. musciformis,
the least inhibited strains were Micrococcus
luteus and MOF 2 isolate at 30°C at 1.0% level.
The methanol extract of H. musciformis
exhibited 100% inhibition towards the Gram
+ve and Gram -ve strains at 10% level at 20°C.
The antibacterial activity of H. musciformis
extracts was found to be effective even at
0.01% giving 66.66% inhibition of tested Gram
+ve bacteria at 30°C and 33% at 20°C. It was
also observed that crude H. musciformis
extracts were less effective (1 to 30 mm2) at
30°C in lower concentrations. Among the fish
pathogens, MOF 2 isolate was found to be
sensitive (Table-3).
The methanol extract of H. valentiae
extracts was found to be most active at 0.01%
against Staphylococcus aureus, Vibrio
fischeri, V. alginolyticus, Pseudomonas
aeruginosa and Micrococcus luteus at 20°C.
It was also assumed that Hypnea valentiae
produced less inhibitory potential towards
Aeromonas hydrophila at 30°C. Gram -ve
bacterium Vibrio alginolyticus was much
sensitive towards H. valentiae methanol
extract at a low concentration of 0.01% at both
the incubated temperatures (Table-4). In the
case of H. musciformis, the Gram +ve strains
were more susceptible in methanol extract
compared to their respective aqueous extract.
In the aqueous extract of H. valentiae, the
Gram +ve strains had 66.66% and 100%
inhibition at 30°C and 20°C respectively, while
the Gram -ve strains produced 71.42% and
85.71% at 30°C and 20°C respectively.
Aeromonas hydrophila was found to be
resistant in the aqueous extract of H.
valentiae.
Among the eluted 5 fractions of
Hypnea musciformis, the active fractions
noted were H4 (against Pseudomonas
aeruginosa and Micrococcus luteus), HB1a
(against Vibrio alginolyticus and A.
hydrophila) and HB2b (against
Staphylococcus aureus) with an inhibitory
potential of >100 mm2. The Gram +ve strain of
Micrococcus luteus (109.3 mm2) and Gram -ve
strain of Pseudomonas aeruginosa (113.04
mm2) exhibited highest inhibitory potential
towards H4 (Hexane -100%) fraction. Among
the very active fractions, the resistant noted
were H4 against Vibrio fischeri and HB1a
against Staphylococcus aureus and MOF 2.
The 1.0% of crude extract of H. musciformis
exhibited an active range of inhibition against
the bacterial isolates of Pseudomonas
aeruginosa, Serratia marcescens,
Micrococcus luteus and MOF 2 isolates.
Fractionated same extracts also showed more
or less same range of # 6.54 mm2 inhibition
towards the same bacterial strains. Similarly,
an active range of # 60 mm2 inhibition was
exhibited by the crude as well as the
fractionated extracts towards the isolates of
Staphylococcus aureus, Serratia marcescens,
Vibrio alginolyticus and Aeromonas
hydrophila. Among the Gram +ve strains,
highest inhibition was produced by
Staphylococcus aureus (86.54 mm2) against H2
fraction and Micrococcus luteus (86.54 mm2) and
Bacillus subtilis (96.71 mm2) against HB1a
fraction. In the case of Gram -ve strains, Vibrio
alginolyticus (96.71 mm2), Pseudomonas
aeruginosa and Aeromonas hydrophila (86.54
mm2) were sensitive against H4 while Serratia
marcescens was sensitive against H4 and MOF1
(86.54 mm2) was sensitive against HB1a.
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Table-3. Antibacterial activity in different concentrations of Hypnea musciformis
 Concentrations (%)
Test organisms          10          1          0.1          0.01         0.001       Control
  30°C 20°C 30°C 20°C 30°C 20°C 30°C 20°C 30°C  20°C
Clinical pathogens
Staphylococcus aureus Mtl +++ +++ + ++ + + - + - - -
Aqs +++ ++++ ++ ++ + + + + - - -
Micrococcus luteus Mtl +++ ++++ + + - + - + - - -
Aqs +++ ++++ + + - + - + - - -
Pseudomonas aeruginosa Mtl +++ ++++ + ++ + + + + - - -
Aqs +++ ++++ + ++ + + + + - - -
Aeromonas hydrophila Mtl ++ +++ + + + + + - - - -
Aqs ++ +++ + + + + + - - - -
Bacillus subtilis Mtl - ++ - - - - - - - - -
Aqs - ++ - - - - - - - - -
Fish pathogens
Serratia marcescens Mtl + + - + - - - - - - -
Aqs +++ +++ - - - - - - - - -
Vibrio  fischeri Mtl ++ +++ + + - - - - - - -
Aqs ++ +++ + + - - - - - - -
Vibrio alginolyticus Mtl +++ +++ + ++ + - - - - - -
Aqs +++ +++ + + + - - - - - -
MOF1(Shrimp isolate) Mtl ++ +++ - ++ - ++ - + - - -
Aqs ++ ++ - ++ - ++ - + - - -
MOF2(Clown fish isolate) Mtl +++ +++ + + + + + + - - -
Aqs - - - - - - - - - - -
Mtl - Methanol extract; Aqs - Aqueous extract; ++++  Maximum active; +++ More active;  ++ Active; +
Minimum active;  - No active
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Table-4.  Antibacterial activity in different concentrations of Hypnea valentiae
 Concentrations (%)
Test organisms          10          1          0.1          0.01         0.001       Control
  30°C 20°C 30°C 20°C 30°C 20°C 30°C 20°C 30°C  20°C
Clinical pathogens
Staphylococcus aureus Mtl +++ ++++ + ++ - + + + - - -
Aqs +++ +++ + + - - - - - - -
Micrococcus luteus Mtl ++++ ++++ +++ +++ ++ ++ - + - - -
Aqs - +++ - ++ - ++ - ++ - - -
Pseudomonas aeruginosa Mtl +++ ++++ + ++ - ++ - + - - -
Aqs ++ +++ + + + + - - - - -
Aeromonas hydrophila Mtl + + - + - - - - - - -
Aqs - - - - - - - - - - -
Bacillus subtilis Mtl +++ +++ + + - + - - - - -
Aqs ++ +++ + + + + + + - - -
Fish pathogens
Serratia marcescens Mtl - - - - - - - - - - -
Aqs + + - + - - - - - - -
Vibrio fischeri Mtl ++ +++ + +++ - + - + - - -
Aqs ++ +++ + ++ + + - - - - -
Vibrio alginolyticus Mtl +++ ++++ ++ +++ + ++ + + - - -
Aqs +++ ++++ ++ +++ + ++ + + - - -
MOF1 (Shrimp isolate) Mtl - +++ - + - - - - - - -
Aqs - +++ - + - + - + - - -
MOF2(Clown fish isolate) Mtl ++ ++ + ++ + + - - - - -
Aqs + + + + - - - - - - -
Mtl - Methanol extract; Aqs - Aqueous extract; ++++  Maximum active; +++ More active;  ++ Active;
+ Minimum active;  - No active
Antibiotic potentials of red macroalgae Hypnea musciformis (Wulfen) Lamouroux 101
Among the Gram +ve strains, the H4
fraction moderately inhibited Staphylococcus
aureus (56.71 mm2) and Bacillus subtilis (58.05
mm2), while HB5a and HB2b fractions inhibited
Staphylococcus aureus (56.71 mm2) and
Bacillus subtilis (31.15 mm2) isolates
respectively. In case of Gram -ve strains, HB5a
and HB2b moderately inhibited V. fischeri,
Vibrio alginolyticus, Aeromonas hydrophila
and MOF 2. The Pseudomonas aeruginosa
was moderately inhibited only by HB2b
fraction. The results also revealed that
Micrococcus luteus and MOF 1 isolates were
less inhibited by HB5a and HB2b fraction
(Table-5).
Among the fractionated extracts of
Hypnea valentiae, the H2 showed very active
inhibitory potential towards Pseudomonas
aeruginosa (109.3 mm2). Dcm/methanol (1:1)
fraction exhibited maximum inhibitory potential
of # 96.71 mm2 and 86.54 mm2 towards Gram
+ve strain of Bacillus subtilis and Gram -ve strain
of Vibrio alginolyticus respectively.
Staphylococcus aureus, Vibrio alginolyticus,
Bacillus subtilis and MOF 2 isolate were
found to be resistant towards ether fraction.
The most resistant isolate noted was MOF 2
(Clown fish isolate) against H2 (Hexane-100%),
ether and acetone fractions. Gram +ve strain of
Micrococcus luteus exhibited moderate range
of inhibition towards H2 and Dcm/methanol
(1:1) fractions. The maximum and minimum
moderate range of inhibitory response was
produced by the Gram +ve isolates of
Staphylococcus aureus (58.05 mm2) and
Micrococcus luteus (3.14 mm2) against Dcm/
methanol (1:1) and Dcm fractions respectively.
The Gram +ve strains of Staphylococcus
aureus (58.05 mm2) and Micrococcus luteus
(31.15 mm2) and Gram -ve strains of Vibrio
fischeri (33.16 mm2), Pseudomonas
aeruginosa (56.71 mm2) and Aeromonas
hydrophila (33.16 mm2) were moderately
sensitive towards Dcm/methanol (1:1) fraction.
In the case of Gram -ve strains very weak
response was produced by Serratia marcescens
against H2 (3.14 mm
2), Dcm/methanol (1:1) (4.90
mm2) and ether (3.14 mm2) fractions. While the
maximum moderate range of inhibitory response
was produced by the Gram -ve isolates of
Pseudomonas aeruginosa (56.71 mm2) against
Dcm/methanol (1:1) and ether and Vibrio
alginolyticus against Dcm fractions (Table-6).
The commercial antibiotics tested produced
greater inhibitory response towards Serratia
marcescens isolate at 20°C. When compared
with standard chloramphenicol, the methanol
extract of Hypnea musciformis and H. valentiae
produced 21.42% more inhibitory potential
towards Gram +ve strain of Staphylococcus
aureus. The methanol and aqueous extract of
Hypnea musciformis extract exhibited very
active range of inhibition towards
Staphylococcus aureus and Pseudomonas
aeruginosa compared to the standard
antibiotics.
Discussion
The results of antibacterial potential
of macroalgae towards Staphylococcus
aureus and Pseudomonas aeruginosa is of
particular significance because of their known
bacterial resistance to various antibiotics
(UNDP, 1994). A series of small molecular
volatile halogenated compounds
(halomethanes, haloether and haloacetales)
also account for the antimicrobial activity.
Padmakumar (1988) reported that the bacterial
flora associated with Ulva lactuca and Hypnea
musciformis showed a significant negative
correlation with the antibacterial activity. The
cell extracts and active constituents of various
algae have been shown to produce
antibacterial activity in vitro against the Gram
+ve and Gram -ve bacteria (Tuney et al., 2006).
Earlier reports suggest that extracts of Indian
macroalgae were active against only Gram +ve
bacteria (Sreenivasa Rao and Parekh, 1981).
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Table-5. Antibacterial study on Hypnea musciformis fractions at 300C (Inhibition zone in mm2)
Gram +ve strains Gram -ve strains
Fractions S.a M.l B.s  S.m V.f V.a P.a A.h MOF1 MOF2
H2 86.54 24.61 R 86.54 3.14 23.74 28.26 34.19 24.61 3.14
H4 56.71 109.3 58.05 41.83 R 96.71 113.04 86.54 109.3 9.61
HB1a R 86.54 96.71 28.26 19.62 113.04 86.54 143.06 86.54 R
HB5a 56.71 12.56 12.56 12.56 33.16 44.15 R 44.15 12.56 33.16
HB2b 113.04 19.62 31.15 31.15 41.83 36.29 38.46 36.29 19.62 44.15
S.a - Staphylococcus aureus; S.m - Serratia marcescens; V.f - Vibrio fischeri; V.a - Vibrio alginolyticus;
P.a - Pseudomonas aeruginosa; M.l - Micrococcus luteus; B.s - Bacillus subtilis; A.h - Aeromonas
hydrophila; MOF 1 - Shrimp isolate; MOF2 - Clown fish isolate; H2&H4 - Hexane (100%); HB1a &
HB5a : Hexane - Benzene (80:20%); HB2b: Hexane-Benzene (60:40%)
Table-6. Antibacterial study on Hyupnea valentiae fractions at 30°C (Inhibition zone in mm2 )
Gram +ve strains Gram -ve strains
Fractions S.a M.l B.s  S.m V.f V.a P.a A.h MOF1 MOF2
H2 86.54 31.15 7.06 3.14 33.16 86.54 109.3 R R R
Dcm 56.71 3.14 R R 28.26 56.71 86.54 33.16 109.3 9.61
Dcm/methanol 58.05 31.15 96.71 4.9 33.16 86.54 56.71 33.16 19.62 23.74
(1:1)
Ether R 12.56 R 3.14 23.74 R 56.71 3.14 R R
Acetone R 19.62 19.62 R R 28.26 36.29 R R R
S.a - Staphylococcus aureus; S.m - Serratia marcescens; V.f - Vibrio fischeri; V.a - Vibrio alginolyticus;
P.a - Pseudomonas aeruginosa; M.l - Micrococcus luteus; B.s - Bacillus subtilis; A.h -Aeromonas hydrophila;
MOF1 - Shrimp isolate; MOF2 - Clown fish isolate; H2 - Hexane (100%); Dcm - Dichloromethane
It was also reported that the Gram +ve strains
were more susceptible to macroalgal crude
extracts than Gram -ve bacterial strains (Rosell
and Srivastava, 1987). But Shanmughapriya
et al. (2008) while discussing about the results
of antimicrobial activity of the fourteen
species of macroalgae collected from the
intertidal zone of southwest coast of India
pointed out that the macroalgae were highly
active against Gram -ve bacteria than Gram +ve
bacteria. The results of the present study
indicated successful inhibition of both Gram
+ve and Gram -ve strains at higher
concentrations. These results are in
agreement with the earlier findings of Selvi et
al. (2001) for the methanol extracts of Hypnea
valentiae, exhibiting higher inhibition against
Gram +ve and Gram -ve bacteria. In the present
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study, methanol extract of  Hypnea
musciformis inhibited 66% of Gram +ve bacteria,
although the activity was narrowed towards
Gram -ve bacteria in aqueous extract of H.
musciformis. The extract of Enteromorpha
compressa, Cladophoropsis zollingeri,
Padina gymnospora, Sargassum wightii and
Gracilaria corticata were active against Gram
+ve Bacillus (Rao, 1991). According to
Gonzalez del Val et al. (2001), the algal extracts
of Enteromorpha ramulosa and Dictyopteris
membranacea were active against both Gram
+ve and Gram -ve strains.
Kandhasamy and Arunachalam
(2008) studied the methanol extract of H.
musciformis extract and indicated their less
activity towards Staphylococcus aureus (12
± 0.69 mm) and Pseudomonas aeruginosa (12
± 0.95 mm). In contrast, the results of antibiotic
screening gave active inhibitory range of
113.04 mm2 towards S. aureus and P.
aeruginosa. It was also noted that the
methanol extract of H. valentiae extracts was
found to be most active at 0.01% against
Staphylococcus aureus, Vibrio fischeri, V.
alginolyticus, Pseudomonas aeruginosa and
Micrococcus luteus at 20°C. According to
Hornsey and Hide (1974), volatile compounds
such as fatty acids, terpenes and carbonyls
from Rhodophyceae (Porphyra, Digenia,
Hypnea), Phaeophyceae (Sargassum,
Laminaria) and Chlorophyceae
(Enteromorpha, Codium, Ulva) were active
at very low concentration on pathogenic
bacteria. The present results revealed that the
incubation temperature considerably
influenced the antibiosis of extracts. In certain
cases, the inhibitory activity was significantly
increased at 20°C. At the lower incubation
temperature, the bacterial growth could have
been reduced and therefore the activity of
extracts was increased at 20°C. In the present
study also the MOF 1 isolate was found to be
resistant at 30°C and regained a nearly active
inhibitory range of 63.58 mm2 at 20°C in
Hypnea valentiae methanol extract. However,
among the Gram +ve bacteria, not all the target
strains tested were equally susceptible to the
antimicrobial metabolites produced. In the
present study, the absence of very active
range of inhibitory response was noted among
the Gram +ve strains of Micrococcus luteus
and Bacillus subtilis towards the methanol
extract of H. musciformis. This could indicate
the presence of some masking factors as
reported by Sreenivasa Rao and Parekh (1981).
Fraction HB5a (Hexane-Benzene
(80:20%) of H. musciformis exhibited potent
activity not only against Gram -ve bacteria but
also against Gram +ve strain of Staphylococcus
aureus. Similar observations were made by
Vlachos et al. (1997) that fractionation of crude
extracts enhanced their activity against both
Gram -ve as well as Gram +ve pathogens. The
antibacterial activity found in hexane extracts
showed the success of the non-polar
hydrophobic extracts independent of diffusion
parameters in the assay method employed
(Choudhury et al., 2005). Higher inhibition
activity yielded by methanol extract than n-
hexane and benzene fractions indicated that
some of the chemical compounds are more
soluble in methanol than other solvents (Zineb
et al., 2004). Methanol as the best solvent for
extracting the effective antimicrobial materials
from the algae species used in this experiment
also coincided with the earlier findings of
Selvin and Lipton (2004). They reported the
antibacterial activity of the methanol extracts
of same algal species. In marine plants, it was
observed that the biological activities mainly
reside in the polar fractions (Guzman et al.,
2001). Studies concerning the effectiveness
of extraction methods highlighted that
chloroform was better than methanol and
Benzene (Febles et al., 1995). However, higher
inhibition rate shown by the n-Hexane fraction
of Hypnea valentiae indicating the
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intermediary and non-polar nature of some
active compounds. Guzman et al. (2001) also
reported that chloroform, alcohol and acetone
extracts of H. musciformis were inhibitory to
pathogenic bacteria viz. Pseudomonas,
Staphylococcus and Salmonella. The present
study also revealed the minimum activity of
aqueous extract in all the tested Gram +ve
strains. This may complement the explanation
of the hypothesis developed for the methanol
extract, which suggest that the partial
inhibition could be due to the partial extraction
of the active compounds which are more
extractable by methanol than by water (Zineb
et al., 2004).
The differences in antimicrobial
activity observed between the methanol,
aqueous and fractionated extracts of
macroalgae could be attributed to the
intraspecific variability in producing
secondary metabolites, influenced by
seasonal changes (Lima-Filho et al., 2002).
Secondly, there could be differences in the
capability of the extraction protocols to recover
the active metabolites and differences in the
assay methods that would result in different
susceptibilities of the target strains as
suggested by Gonzalez del Val et al. (2001). It
is clear that organic solvents provided a higher
efficiency in extracting compounds for
antimicrobial activities compared to water-
based extraction methods (Lima-Filho et al.,
2002). The results of present study revealed
that methanol extract of Hypnea musciformis
produced very active range of inhibitory
pattern (113.04 mm2) towards Gram -ve strain
of Vibrio alginolyticus while the aqueous
extract of same produced only active range of
inhibition of 94.98 mm2 at 20°C.
According to Patra et al. (2008), the
methanol extract of Sargassum sp. possesses
strong antimicrobial activity against Gram +ve
strain of Staphylococcus aureus when
compared with Ampicillin as the standard. In
the present study also, the methanol extract
of Hypnea musciformis and H. valentiae could
be considered as valuable  alternative to the
tested commercial antibiotics since this extract
successfully inhibited both Gram +ve and Gram
-ve strains of Staphylococcus aureus, Vibrio
alginolyticus and Pseudomonas aeruginosa.
Kandhasamy and Arunachalam (2008)
reported that the crude extract of Hypnea
musciformis produced high antibiotic
susceptibility against Pseudomonas
aeruginosa, Micrococcus luteus,
Staphylococcus aureus and Bacilus subtilis
when compared with standard
Chloramphenicol.  In the present study,
methanol extract of Hypnea musciformis
exhibited very active range of inhibitory
response against Staphylococcus aureus and
Pseudomonas aeruginosa (113.04 mm2)
compared to all the tested commercial
antibiotics. The activity of the macroalgal
methanol and other solvent extracts will lead
to the findings of natural antimicrobial agents
as alternatives to the existing antibiotic, which
is already resistant to the pathogens,
especially in the treatment of Methicillin-
Resistant Staphylococcus aureus (MRSA).
However, systematic investigations regarding
toxicity, stability and metabolism of
macroalgae and macroalgal compounds need
to be undertaken.
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